Combined-modality therapy of head and neck cancer

ONCOLOGY

Volumn 11, Issue 9 SUPPL., 1997, Pages 27-30

  Vokes, Everett E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; NAVELBINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; HEAD AND NECK CANCER; HUMAN; META ANALYSIS; MULTIMODALITY CANCER THERAPY; SURVIVAL RATE; TREATMENT PLANNING; TUMOR LOCALIZATION;

ANTINEOPLASTIC AGENTS; CISPLATIN; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; NASOPHARYNGEAL NEOPLASMS; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIALS;

EID: 0030855926     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Parker SL, Tong T, Bolden S, et al: Cancer statistics, 1996. CA Cancer J Clin 65:5-27, 1996.
2. Vokes EE, Weichselbaum RR, Lippman S, et al: Head and neck cancer. N Engl J Med 328:184-194, 1993
3. Vokes EE, Athanasiadis I: Chemotherapy for squamous cell carcinoma of head and neck: The future is now. Ann Oncol 7:15-29, 1996.
4. Brockstein BE, Vokes EE: Chemoradiotherapy for head and neck cancer. Principles and Practice of Oncology Updates 10:1-19, 1996.
5. Dimery IW, Hong WK: Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 85:95-111, 1993.
6. Forastiere AA, Metch B, Schuller DE, et al: Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil vs methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10:1245-1251, 1992.
7. Jacobs C, Lyman G, Velez-Garcia E, et al: A phase HI randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10:257-263, 1992.
8. Schrijvers D, Johnson J, Jacob H, et al: Modulation of cisplatin/5-FU chemotherapy by interferon alfa in patients with recurrent or metastatic head and neck cancer: A phase III trial of the Head and Neck Interferon Cooperative Study Group (abstract). Proc Am Soc Clin Oncol 15:312, 1996.
9. Vokes EE, Panje WR, Schilsky RL, et al: Hydroxyurea, 5-fluorouracil and concomitant radiotherapy in poor prognosis head and neck cancer: A phase I-II study. J Clin Oncol 7:761-768, 1989.
10. Vokes EE, Haraf DJ, Mick R, et al: Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol 12:2351-2359, 1994.
11. Haraf DJ, Weichselbaum RR, Vokes EE: Reirradiation of unresectable recurrent head and neck cancer: A potentially curable disease. Ann Oncol 7:913-918, 1996.
12. Gandia D, Wibault P, Guillot T, et al: Simultaneous chemoradiotherapy as salvage treatment in locoregional recurrences of squamous head and neck cancer patients. Head Neck 15 15-23, 1993.
13. Weppelmann B, Wheeler RA, Peters GE, et al: Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation. Int J Radiat Oncol Biol Phys 22:1051-1056, 1992.
14. Hartsell WF, Thomas CR Jr, Murthy AK, et al: Pilot study for the evaluation of simultaneous cisplatin/5-fluorouracil infusion and limited radiation therapy in regionally recurrent head and neck cancer (EST P-C385). Am J Clin Oncol 17:338-343, 1994.
15. Rooney M, Kish J, Jacobs J, et al: Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin Cancer 55:1123-1128, 1985.
16. Thyss A, Schneider M, Santini J, et al: Induction chemotherapy with cisplatinum and 5-fluorouracil for squamous cell carcinoma of the head and neck. Br J Cancer 54-755-760, 1986.
17. Kies MS, Gordon LI, Hauck WW, et al: Analysis of complete responders after initial treatment with chemotherapy in head/neck cancer. Orolaryng Head Neck Surg 93:199-205, 1985.
18. Ervin TJ, Clark JR, Weichselbaum RR, et al: An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J Clin Oncol 5:10-20, 1987.
19. Vokes EE, Mick R, Lester EP, et al: Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: Results from a single institution. J Clin Oncol 9:1376-1384, 1991.
20. Jacobs C, Goffinet DR, Goffinet L, et al: Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 60:1178-1183, 1987.
21. Head and Neck Contracts Program: Adjuvant chemotherapy for advanced head and neck squamous carcinoma: Final report. Cancer 60:301-311, 1987.
22. Jacobs C, Makuch R: Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: A subset analysis of the Head and Neck Contracts Program. J Clin Oncol 8:838-847, 1990.
23. Laramore GE, Scott CB, al-Sarraf M et al: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on intergroup study. Int J Radiat Oncol Biol Phys 23:705-713, 1992.
24. Schuller DE, Metch B, Stein DW, et al: A Preoperative chemotherapy in advanced resectable head and neck cancer' Final report of the Southwest Oncology Group. Laryngoscope 98:1205-1211, 1988.
25. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1991
26. Paccagnella A, Orlando A, Marcniori C, et al: Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 86:265-272, 1994.
27. Lefebvre J-L, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88:890-899, 1996.
28. Vokes EE, Haraf DJ, Weichselbaum RR, et al: Head and Neck Cancer, vol 3, pp 321-326. Excerpta Medica International Congress Series 1009, 1993.
29. Vokes EE, Weichselbaum RR: Concomitant chemoradiotherapy: Rationale and clinical experience in patients with solid tumors. J Clin Oncol 8:911-934, 1990.
30. Vokes EE. Interactions of chemotherapy and radiation. Semin Oncol 20:70-76, 1993.
31. Lo TC, Wiley AL Jr, Ansfield FJ, et al: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study Am J Roentgenol 126:229-235, 1976.
32. Browman GP, Cripps C, Hodson DI, et al: Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer. J Clin Oncol 12:2648-2653, 1994.
33. Haffty BG, Son KH, Papac R, et al: Chemotherapy as an adjunct to radiation therapy in the treatment of squamous cell carcinoma of the head and neck: Results from the Yale mitomycin-C randomized clinical trials (abstract). Proc Am Soc Clin Oncol 15:316, 1996.
34. Gupta NK, Pointon RC, Wilkinson PM: A randomized clinical trial to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer Clin Radiat 38:575-581, 1987.
35. cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 5:1410-1418, 1987.
36. Bauchaud JM, David JM, Boussin G, et al: Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carnoma of the head and neck: Preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 20: 243-246, 1991.
37. El-Sayed S, Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carnimoa of the head and neck region: A meta-analysis of prospective and randomized trials. J Clin Oncol 14:838-847, 1996.
38. Merlano M, Benasso M, Corvo R, et al: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583-589, 1996
39. Parsons JT, Medenhall WM: Re: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck (letter). J Natl Cancer Inst 88:1407, 1996: Merlano M: Response to letter. J Natl Cancer Inst 88:1407-1408, 1996.
40. Parsons JT, Medenhall WM: Re: Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck (letter). J Natl Cancer Inst 88:1407, 1996: Merlano M: Response to letter. J Natl Cancer Inst 88:1407-1408, 1996.
41. Vokes EE, Weichselbaum RR, Mick R, et al: Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer, J Natl Cancer Inst 84:877-882, 1992.
42. Vokes EE, Kies M, Haraf DJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 13: 876-883, 1995.
43. Vokes EE, Stupp R, Haraf D, et al: Hydroxyurea with continuous infusion paclitaxel, 5-fluorouacil and concomitant radioterapy for poor prognosis head and neck cancer. Semin Oncol (suppl 6):22:47-52, 1995.
44. Adelstein DJ, Kalish LA, Adams GL, et al: Concurrent radiotherapy and chemotherapy for locally unresectable squamous cell head and neck cancer: An ECOG pilot study. J Clin Oncol 11:2136-2142, 1993.
45. Leyvraz S, Pasche P, Bauer J, et al: Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: Four-year results of a phase I/II study. J Clin Oncol 12:1876-1885, 1994.
46. Taylor SG IV, Murthy AK, Vannetzel J-M, et al: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation vs concomitant treatment in advanced head and neck cancer. J Clin Oncol 12:385-395, 1994.
47. Kies MS, Haraf DJ, Mittal B, et al: Intensive combined therapy with C-DDP, 5-FU, hydroxyurea, and BID radiation (C-FHX) for stage IV squamous cancer of the head and neck (abstract). Proc Am Soc Clin Oncol 15;314, 1996.
48. Wibault P, Bensmaine MEA, de Forni M, et al: Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: A phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil. J Clin Oncol 14:1192-1200, 1996.
49. Fandi A, Altun M, Azli N, et al: Nasopharyngeal cancer: Epidemiology, staging, and treatment. Semin Oncol 21:382-397, 1994.
50. Cvitkovic E: Neoadjuvant chemotherapy with epirubicin, cisplatin, bleomycin in undifferentiated nasopharyngeal cancer: Preliminary results of an international phase 111 trial (abstract). Proc Am Soc Clin Oncol 13:283, 1994.
51. Al-Sarraf M, LeBlanc M, Giri PGS, et al: Superiority of chemoradiotherapy vs radiotherapy in patients with locally advanced nasopharyngeal cancer Preliminary results of Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) randomized study (abstract). Proc Am Soc Clin Oncol 15:313, 1996.
52. Chan ATC, Teo PML, Leung TWT, et al: A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33, 569-577, 1995.
53. Teo PML, Leung TWT, Chan ATC, et al: A retrospective study of the use of cisplatinum-5-fluoroucil neoadjuvant chemotherapy in cervical-node-positive nasopharyngeal carcinoma. Eur J Cancer Oral Oncol 31B:373-379, 1995.